Journal of Adolescent and Young Adult Oncology

Scope & Guideline

Advancing Knowledge, Enhancing Lives in Young Oncology

Introduction

Immerse yourself in the scholarly insights of Journal of Adolescent and Young Adult Oncology with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageEnglish
ISSN2156-5333
PublisherMARY ANN LIEBERT, INC
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 2014 to 2024
AbbreviationJ ADOLESC YOUNG ADUL / J. Adolesc. Young Adult Oncol.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801

Aims and Scopes

The Journal of Adolescent and Young Adult Oncology aims to advance the understanding and treatment of cancer in adolescents and young adults (AYAs), focusing on the unique challenges faced by this population. It encompasses a broad range of interdisciplinary research, addressing medical, psychological, social, and economic aspects of cancer care for AYAs.
  1. Oncofertility and Reproductive Health:
    A significant focus on the implications of cancer treatment on fertility and reproductive health, including strategies for fertility preservation and psychosocial support for survivors.
  2. Psychosocial Impact and Support:
    Research examining the psychological, emotional, and social challenges faced by AYAs with cancer, including the development and evaluation of supportive care interventions.
  3. Health Care Transition and Coordination:
    Studies exploring the transition from pediatric to adult oncology care, emphasizing the need for tailored approaches to meet the unique needs of AYAs.
  4. Long-term Survivorship and Quality of Life:
    Investigations into the long-term effects of cancer treatment on survivors' quality of life, including physical health, mental well-being, and social reintegration.
  5. Clinical Outcomes and Treatment Innovations:
    Research involving clinical trials, treatment efficacy, and innovative therapies specifically tailored for the adolescent and young adult age group.
The Journal of Adolescent and Young Adult Oncology has identified several emerging themes in recent research that reflect the evolving landscape of oncology care for adolescents and young adults. These trends highlight the growing recognition of the unique challenges faced by this population and the need for targeted research and interventions.
  1. Integration of Telehealth in Oncology Care:
    The rise of telehealth services has become a significant trend, particularly in the context of providing accessible care and support to AYAs during and after the COVID-19 pandemic.
  2. Focus on Mental Health and Well-Being:
    A notable increase in research addressing the mental health challenges of AYAs with cancer, including anxiety, depression, and coping strategies, reflecting a broader understanding of holistic care.
  3. Financial Toxicity and Economic Burden:
    Emerging studies focusing on the financial implications of cancer treatment for AYAs, including the impact of financial stress on decision-making regarding treatment and survivorship.
  4. Peer Support Programs:
    Growing interest in peer support interventions that leverage the experiences of AYAs with cancer to provide relatable support and improve psychosocial outcomes.
  5. Exploration of Social Media as a Support Tool:
    Research into the role of social media in providing emotional support and information sharing among AYAs has gained traction, recognizing its importance in modern communication.

Declining or Waning

While the Journal of Adolescent and Young Adult Oncology continues to evolve, certain areas of research are witnessing a decline in focus. These waning themes may reflect changing priorities within the field, advancements in treatment approaches, or shifts in the interests of the research community.
  1. Traditional Chemotherapy Studies:
    There seems to be a reduced emphasis on studies solely focused on traditional chemotherapy regimens, as the field shifts towards exploring targeted therapies and personalized medicine for AYAs.
  2. Single-Symptom Management Research:
    Research concentrated on isolated symptoms, such as pain or nausea, is becoming less prominent in favor of holistic approaches that address multiple symptoms and overall quality of life.
  3. General Cancer Awareness Campaigns:
    The focus on broad cancer awareness initiatives is declining, with a shift towards more specific interventions that address the unique needs of AYAs, such as oncofertility and psychosocial support.

Similar Journals

JNCI-Journal of the National Cancer Institute

Shaping the future of oncology through rigorous research.
Publisher: OXFORD UNIV PRESS INCISSN: 0027-8874Frequency: 12 issues/year

JNCI-Journal of the National Cancer Institute, published by Oxford University Press Inc. in the United Kingdom, is a premier journal dedicated to advancing the field of cancer research and oncology. With a distinguished history dating back to 1940, this journal has consistently maintained a strong reputation within the academic community, achieving a remarkable Q1 ranking in both Cancer Research and Oncology as of 2023. Researchers and practitioners rely on the JNCI for original research articles, review papers, and cutting-edge findings that impact clinical practices and therapeutic strategies. Although it does not currently offer open access, the journal remains a vital resource for academicians and healthcare professionals seeking to enhance their understanding of cancer mechanisms and treatment innovations. Its rigorous peer-review process ensures the publication of high-quality, credible research that meets the evolving challenges of cancer treatment and prevention through to 2024.

ESMO Open

Empowering oncology through open access innovation.
Publisher: ELSEVIERISSN: Frequency: 6 issues/year

ESMO Open is a premier open-access journal published by Elsevier, dedicated to advancing research in the fields of cancer and oncology. Since its inception in 2016, the journal has established itself as a vital resource for researchers, clinicians, and healthcare professionals, providing a platform for disseminating high-quality, peer-reviewed research. With an impressive Q1 ranking in both Cancer Research and Oncology based on the 2023 category quartiles, ESMO Open ranks within the top tier of its field, showcasing its commitment to excellence and innovation. The journal’s inclusion in Scopus rankings further emphasizes its significant impact, with remarkable placements in the 88th and 83rd percentiles for Oncology and Cancer Research, respectively. Operating under an open access model, ESMO Open ensures that cutting-edge findings and insights are readily available to the global academic community, fostering collaboration and knowledge-sharing to further enhance the understanding and treatment of cancer.

Indian Journal of Medical and Paediatric Oncology

Advancing pediatric oncology through innovative research.
Publisher: THIEME MEDICAL PUBL INCISSN: 0971-5851Frequency: 4 issues/year

Indian Journal of Medical and Paediatric Oncology, published by THIEME MEDICAL PUBL INC, serves as a crucial platform for disseminating research and clinical studies in the realms of oncology and paediatrics. With an ISSN of 0971-5851 and an E-ISSN of 0975-2129, this journal plays a pivotal role in addressing the challenges and advancements in important areas of child health and cancer treatment. Although the journal is currently ranked in the Q4 category for both Oncology and Pediatrics, Perinatology and Child Health, its ongoing commitment to publishing quality research from 2009 to 2024 signifies its relevance in the academic community. Positioned in India and accessible to a global audience, this journal aims to foster a comprehensive understanding of medical and paediatric oncology, thereby influencing clinical practices and enhancing patient care. Researchers, practitioners, and students alike can benefit from its diverse range of articles, offering insights into the latest scientific discoveries and therapeutic approaches in these critical fields.

Asia-Pacific Journal of Oncology Nursing

Fostering Excellence in Oncology Nursing Research and Practice
Publisher: ELSEVIER SCIENCE INCISSN: 2347-5625Frequency: 12 issues/year

Asia-Pacific Journal of Oncology Nursing, published by Elsevier Science Inc, serves as a vital resource for researchers, practitioners, and students involved in the fields of oncology and nursing within the Asia-Pacific region. Since its transition to Open Access in 2014, the journal has aimed to disseminate cutting-edge research and innovative practices that enhance the quality of nursing care in oncology. With its ISSN 2347-5625 and E-ISSN 2349-6673, this journal holds a Q3 rank in both Oncology and Nursing (Oncology Nursing) as of 2023, reflecting its commitment to addressing current challenges and advancements in the discipline. With a Scopus ranking of 252/404 in Medicine (Oncology) and 13/20 in Nursing (Oncology Nursing), it occupies a crucial position in the academic landscape, nurturing knowledge that directly impacts patient care in oncology settings. Located at STE 800, 230 Park Ave, New York, NY 10169, the journal encourages contributions that explore multifaceted aspects of oncology nursing from 2018 to 2024, making it an important platform for emerging voices and established experts alike.

JNCI Cancer Spectrum

Transforming cancer insights into impactful discoveries.
Publisher: OXFORD UNIV PRESSISSN: Frequency: 6 issues/year

JNCI Cancer Spectrum, published by Oxford University Press, is a leading open-access journal dedicated to advancing the field of cancer research and oncology. With an impressive impact demonstrated through its Q1 ranking in both Cancer Research and Oncology categories for 2023, this journal provides a vital platform for disseminating high-quality research and innovative findings in a rapidly evolving landscape. Since its inception in 2017, JNCI Cancer Spectrum has embraced open access, enhancing the accessibility of evidence-based knowledge to researchers, professionals, and students across the globe. Additionally, it boasts notable positions in Scopus rankings, with a strong performance in both the Medicine and Biochemistry, Genetics and Molecular Biology categories. The journal is committed to its objectives of fostering collaborative efforts and encouraging dialogue among experts, making it an essential resource for anyone involved in cancer research.

Gynecologic Oncology

Leading the Charge in Obstetrics and Gynecology Research
Publisher: ACADEMIC PRESS INC ELSEVIER SCIENCEISSN: 0090-8258Frequency: 12 issues/year

Gynecologic Oncology, an esteemed journal published by Academic Press Inc Elsevier Science, stands at the forefront of research in the domains of Obstetrics and Gynecology and Oncology. With an exceptional track record dating from 1972 to 2024, this journal has established itself as a vital resource for scholars and practitioners alike, boasting a remarkable Q1 ranking in both fields as of 2023. Gynecologic Oncology not only ranks #13 out of 209 in Obstetrics and Gynecology and #72 out of 404 in Oncology but also operates within the top percentiles of academic influence, with a 94th percentile in Obstetrics and Gynecology and an 82nd percentile in Oncology on Scopus. Although the journal does not currently offer open access, it remains crucial for disseminating original research, reviews, and advances in the management and treatment of gynecological cancers. Researchers and health professionals will find this journal indispensable for staying informed on the latest advancements and breakthroughs in this vital area of medicine, fostering a deeper understanding and potentially transforming patient care practices.

ONCOLOGY-NEW YORK

Nurturing Excellence in Oncology Research and Education.
Publisher: UBM MEDICAISSN: 0890-9091Frequency: 12 issues/year

ONCOLOGY-NEW YORK is a prominent journal dedicated to the field of oncology, published by UBM MEDICA. Since its inception in 1987, the journal has served as a pivotal platform for disseminating groundbreaking research and advancements in cancer treatment, research, and education. With an ISSN of 0890-9091 and an E-ISSN of 2767-7389, it stands as an accessible resource for professionals, researchers, and students alike. The journal currently holds impressive rankings, categorized within Q3 in Oncology and Q4 in Cancer Research for 2023, reflecting its commitment to high-quality research output and contributions to the field. Despite its challenges in Scopus rankings, positioned at #283/404 in Medicine: Oncology and #188/230 in Biochemistry, Genetics, and Molecular Biology: Cancer Research, ONCOLOGY-NEW YORK continues to primarily focus on innovative cancer therapies and emerging clinical research. The journal's ongoing dedication to enhancing knowledge and understanding in oncology makes it a vital resource for all stakeholders invested in combating cancer.

LANCET ONCOLOGY

Unveiling breakthroughs in oncology and patient care.
Publisher: ELSEVIER SCIENCE INCISSN: 1470-2045Frequency: 12 issues/year

The Lancet Oncology is a premier peer-reviewed journal published by Elsevier Science Inc., recognized as a leading authority in the field of oncology. With an ISSN of 1470-2045 and E-ISSN 1474-5488, this esteemed journal boasts an impressive 2023 impact factor placing it in the Q1 category of oncology—reflecting its role as a critical resource for cutting-edge research. The journal publishes high-quality articles covering novel scientific discoveries, clinical advancements, and public health issues related to cancer treatment and prevention. It is ranked #5 out of 404 in the Scopus Medicine _ Oncology category, demonstrating its influence and relevance in the field, with an outstanding rank in the 98th percentile. Operating from its base in the United Kingdom, The Lancet Oncology spans a comprehensive timeframe from 2000 to 2024, making it a vital repository of oncology literature. Although it does not primarily operate on an open-access model, its significant subscription base ensures that a wealth of knowledge is accessible to researchers, professionals, and students alike, fostering a profound understanding and advancement in oncology.

PERSPECTIVES ON SEXUAL AND REPRODUCTIVE HEALTH

Innovating insights in reproductive health disciplines.
Publisher: WILEYISSN: 1538-6341Frequency: 4 issues/year

PERSPECTIVES ON SEXUAL AND REPRODUCTIVE HEALTH is a renowned scholarly journal published by Wiley, focusing on the comprehensive fields of reproductive health and sexual wellness. With an impressive 2023 impact factor placing it in the Q1 category across multiple disciplines—including Obstetrics and Gynecology, Public Health, and Sociology and Political Science—this interdisciplinary journal offers a vital platform for researchers, professionals, and students dedicated to advancing knowledge and practice in these critical areas. Established in 1996 and converging through to 2024, the journal provides open access options, ensuring wide dissemination of its impactful articles. The journal combines rigorous empirical research with significant policy discussions, making it a crucial resource for those committed to improving sexual and reproductive health outcomes globally.

Frontiers in Oncology

Connecting researchers to revolutionize oncology.
Publisher: FRONTIERS MEDIA SAISSN: 2234-943XFrequency: 1 issue/year

Frontiers in Oncology is a premier open access journal dedicated to advancing the field of oncology through innovative research and knowledge dissemination. Published by FRONTIERS MEDIA SA since 2011, this journal is based in Switzerland and holds an impressive Q2 ranking in both Cancer Research and Oncology as of 2023, highlighting its significance in the academic community. With its commitment to open access, Frontiers in Oncology ensures that vital research is readily available to researchers, healthcare professionals, and students around the globe, enhancing collaboration and fostering breakthroughs in cancer research. The journal's robust Scopus rankings further illustrate its academic influence, with notable positions in the fields of Oncology and Cancer Research. By covering a wide range of topics within oncology, this journal serves as a vital resource, supporting the rapid evolution of cancer treatment, diagnostics, and patient care strategies.